Hagnous Bioceuiticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 27.16%
- Profit Growth 31.87%
- Ebitda 0.21%
- Net Worth 11.61%
- Total Assets 9.12%
About Hagnous Bioceuiticals
Hagnous Bioceuiticals Private Limited (HBPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 November 2013 and has a history of 11 years and three months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Elangovan Mari and Shivaganga Swathi serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110KA2013PTC071702
- Company No.
071702
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Hagnous Bioceuiticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Elangovan Mari  | Director | 06-Nov-2013 | Current |
| Shivaganga Swathi | Director | 01-Feb-2021 | Current |
Financial Performance of Hagnous Bioceuiticals.
Hagnous Bioceuiticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.16% increase. The company also saw a substantial improvement in profitability, with a 31.87% increase in profit. The company's net worth Soared by an impressive increase of 11.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hagnous Bioceuiticals?
In 2020, Hagnous Bioceuiticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trion Weblore Technologies Private LimitedShivaganga Swathi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hagnous Bioceuiticals?
Hagnous Bioceuiticals has a workforce of 6 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hagnous Bioceuiticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hagnous Bioceuiticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
